2014-06-26 12:57:19 UTC

Your GI Research May Create the Next New Drug

July 3, 2014

Apply by July 28 to be considered to work directly with an international pharmaceutical company and bring your research to life.

Are you interested in working with a commercial partner to bring your GI research to life?

Funded by Takeda Pharmaceuticals International, Inc. and the AGA Research Foundation, researchers are invited to submit a summary of their concept for collaboration that could yield a new drug or molecular diagnostic relevant to celiac disease or GI motility disorder (particularly those involving neural/ hormonal dysfunction or the gut microbiome). The deadline to submit an application is July 28, 2014.

The most promising will be invited to present their concepts in person at a private conference held at Takeda Pharmaceuticals International, Inc. headquarters near Chicago on Oct. 8, 2014, and may be chosen to work directly with this international company to further develop their promising ideas.

View additional details and apply at www.gastro.org/discovery.

More on Celiac Disease

The Lowdown on the Low-FODMAP Diet

Nov. 1, 2017

As the low-FODMAP diet grows in popularity, know the facts to help answer patient questions and provide guidance.

Spotlight on Fellow-Led Quality Improvement Projects

Oct. 3, 2017

These 19 projects presented at DDW® 2017 showcase the extensive work being done by fellows to improve the quality of care provided to GI patients.

Avoidance of Cow's Milk–Based Formula for At-Risk Infants Does Not Reduce Development of Celiac Disease: A Randomized Controlled Trial

Oct. 1, 2017

Increased cow's milk antibody titers before the appearance of anti-TG2A and celiac disease indicates that subjects with celiac disease might have increased intestinal permeability in early life.